GamEMab

N/A

Report date: 2022/12/31 19:21:23

Base Information

Drug NameGamEMab
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionCytokines inhibitors
TargetsCytokines
Therapy Area/IndicationsHemorrhagic Fever, Ebola
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryRussian Federation
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesGamaleya Research Institute Of Epidemiology And Microbiology
China Registration ClassN/A

Develop Information

Active CompaniesGamaleya Research Institute Of Epidemiology And Microbiology
Inactive CompaniesGamaleya Research Institute Of Epidemiology And Microbiology, Health Ministry Of The Russian Federation
Active IndicationsHemorrhagic Fever, Ebola
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A